HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.
Harry Harper, MD

Harry Harper, MD

Board Certifications: Hematology, Internal Medicine and Medical Oncology

Languages: English

Locations: Hackensack, NJ

Dr. Harry Harper specializes in medical oncology, hematology and thoracic oncology, and has been treating patients in New Jersey for more than 30 years. Dr. Harper is actively involved in thoracic oncology research. Additionally, he has been awarded the National Merit Scholar Award from Johns Hopkins University and the Alpha Omega Award from the National Medical Honor Society.

Education

Medical Education

Baylor College of Medicine, medical degree

Residency

New York Hospital, residency in internal medicine

fellowship

Memorial Sloan-Kettering Cancer Center, fellowship training in medical oncology hematology

Awards and honors

Awards and honors

  • Jersey’s Best Magazine Top Doctors: 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024
  • Jersey’s Best – Top Doctors for Cancer: 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2021, 2022, 2023, 2024
  • New York Magazine: Top Doctors: 2013, 2021, 2022
  • Top Doctors: New York Metro Area (book series): 10th Edition, 11th Edition, 12th Edition, 13th Edition, 14th Edition, 15th Edition, 16th Edition, 17th Edition, 18th Edition, 6th Edition, 7th Edition, 8th Edition, 9th Edition
  • Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022

Professional Memberships

membership information

Hospital Affiliations

Hackensack University Medical Center

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.